Fredrick Wolk
Torrance, CANPI 1669426078
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Urogpo LLC at 30.7% of the total. Reporting peaked in 2019 at $4,791 and has fallen 97.6% since, to $115 in 2025.
Across 80 payments — averaging $75.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Urogpo LLC$2K
- Merck$858
- Janssen Scientific Affairs, LLC$758
- Astellas Pharma US Inc$420
- Johnson & Johnson$397
- Dendreon Pharmaceuticals LLC$311
- plus $1K from 17 others
Across 86 payments — averaging $1362.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$48K
- Dendreon Pharmaceuticals LLC$41K
- Janssen Research & Development, LLC$19K
- Ferring International Pharmascience Center US$6K
- Ferring Pharmaceuticals AS$4K
What the payments were for
- Consulting fees$75813%
- Speaking & faculty fees$1062%
- Travel & lodging$1,74829%
- Food & beverage$3,42657%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Urogpo LLC | 2 | $1,856 |
| Merck | 7 | $858 |
| Janssen Scientific Affairs, LLC | 1 | $758 |
| Astellas Pharma US Inc | 16 | $420 |
| Johnson & Johnson | 13 | $397 |
| Dendreon Pharmaceuticals LLC | 8 | $311 |
| Pfizer | 4 | $244 |
| AbbVie(2 entities) | 6 | $197 |
| Bayer | 5 | $157 |
| Genentech USA, Inc. | 1 | $150 |
| Myovant Sciences GmbH | 1 | $125 |
| Ferring Pharmaceuticals Inc. | 1 | $125 |
| Amgen | 1 | $106 |
| Blue Earth Diagnostics | 3 | $86 |
| AstraZeneca | 1 | $79 |
| Endo Pharmaceuticals Inc. | 3 | $41 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| Sagent Pharmaceuticals | 1 | $22 |
| Boston Scientific | 1 | $19 |
| Coloplast | 1 | $18 |
| Avadel Specialty Pharmaceuticals, LLC | 1 | $17 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $17 |
| Metuchen Pharmaceuticals | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.